Tranexamic Acid
Exacyl contains the active substance tranexamic acid. Tranexamic acid belongs to a group of
medicines called antifibrinolytics. The action of tranexamic acid is to inhibit the fibrinolytic activity of plasmin.
Exacyl is used for:
Before starting Exacyl, discuss with your doctor or pharmacist:
You should immediately inform your doctor if you experience any of the following symptoms:
unusual leg pain, muscle weakness, chest pain, irregular pulse, sudden shortness of breath, loss of consciousness, disorientation, severe headache, dizziness, visual disturbances, slurred speech, or loss of speech.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take, including those obtained without a prescription.
In particular, inform your doctor if you are taking:
You should also inform your doctor if you are taking:
Exacyl can be taken with or without food.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should avoid taking this medicine if you are pregnant.
Tranexamic acid passes into breast milk. Breast-feeding is not recommended during treatment with this medicine.
During treatment with Exacyl, dizziness and malaise may occur. If you experience such symptoms, do not drive or operate machinery.
The medicine is suitable for patients with celiac disease.
Patients with wheat allergy (other than celiac disease) should not take this medicine.
If you have previously been diagnosed with intolerance to some sugars, you should consult your doctor before taking the medicine.
This medicine should always be taken exactly as advised by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.
The recommended dose is:
Adults
2 to 4 g per day in 2 or 3 divided doses (i.e., 4 to 8 tablets per day).
Children
20 mg/kg body weight per day.
Tablets should be taken orally.
Patient with Renal Impairment
In case of renal impairment, due to the risk of accumulation of the medicinal product, the dosing of tranexamic acid should be reduced according to the serum creatinine level.
If the serum creatinine level is:
between 120 and 250 μmol/l, the dose of tranexamic acid is 10 mg/kg body weight intravenously, twice a day;
between 250 and 500 μmol/l, the dose of tranexamic acid is 10 mg/kg body weight intravenously, once a day (every 24 hours);
above 500 μmol/l, the dose of tranexamic acid is 5 mg/kg body weight intravenously, once a day (every 24 hours).
As a result of overdose, the following may occur: dizziness of central origin, headache, hypotension, and seizures. Seizures tend to occur more frequently with increasing dose. If you have taken more than the recommended dose of the medicine, seek medical advice immediately.
If you miss a dose, take it as soon as possible, unless it is almost time for your next dose.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4.
Like all medicines, Exacyl can cause side effects, although not everybody gets them.
During treatment with Exacyl, the following side effects have been observed:
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Frequency Not Known(frequency cannot be estimated from the available data):
If you experience any side effects, including any not listed in this leaflet, please tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or its representative in Poland.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C, protect from light.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Tablets are packaged in blisters, placed in a cardboard box.
The pack contains 20 film-coated tablets.
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Germany
Fidelio Healthcare Limburg GmbH
Mundipharmastrasse 2
65549 Limburg
Germany
Opella Healthcare Poland Sp. z o.o.
Branch in Rzeszów
Lubelska Street 52
35-233 Rzeszów
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.